Flow Neuroscience Receives FDA Approval for At-Home Depression Treatment
Photo by Nick Fewings on Unsplash
Flow Neuroscience, a company based in Malmö, has secured FDA premarket approval for their electric brain stimulation headset, which treats depression. U.S. clinics can now prescribe this headset for adult patients with moderate to severe major depressive disorder, making it the first FDA-approved at-home medical device for this purpose.
Key takeaways
- Flow Neuroscience, a Malmö-based company, has received FDA premarket approval for its electric brain stimulation headset used in the treatment of depression, according to Medtech Magazine
- This clearance allows U
- clinics to prescribe the headset to adult patients diagnosed with moderate to severe major depressive disorder
Related Topics
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Check fit (2 min)Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.